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ABSTRACT
Tetracycline resistance can be achieved through tet genes, which code for efflux pumps,
ribosomal protection proteins and inactivation enzymes. Some of these genes have only been
described in either Gram-positive or Gram-negative bacteria. This is the case of tet(B), which
codes for an efflux pump and, so far, had only been found in Gram-negative bacteria. In this
study, tet(B) was detected in two clinical Streptococcus oralis strains isolated from the gingival
sulci of two subjects. In both cases, the gene was completely sequenced, yielding 100%
shared identity and coverage with other previously published sequences of tet(B). Moreover,
we studied the expression of tet(B) using RT-qPCR in the isolates grown with and without
tetracycline, detecting constitutive expression in only one of the isolates, with no signs of
expression in the other one.
This is the first time that the presence and expression of the tet(B) gene has been
confirmed in Gram-positive bacteria, which highlights the potential of the genus
Streptococcus to become a reservoir and a disseminator of antibiotic resistance genes in an
environment so prone to horizontal gene transfer as is the oral biofilm.
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Since their discovery in the 1940s, tetracyclines have
been used for many years to treat a wide spectrum of
infections. However, resistance to these antibiotics
soon appeared, and only the discovery of new deri-
vatives allowed their continued use until the 1980s,
when they were gradually replaced by other antibio-
tics such as fluoroquinolones [1].
Despite their widespread resistance, some tetracy-
clines are still useful in some treatments, such as in
acne vulgaris, periodontitis and infections caused by
multidrug resistant (MDR) Acinetobacter baumannii,
Helicobacter pylori and methicillin-resistant Staphylo-
coccus aureus [2–4]. Resistance can occur through efflux
pumps, ribosomal protection or enzymatic inactivation.
According to http://faculty.washington.edu/marilynr/
(last update May 1st, 2019), 60 tetracycline resistance
genes have been detected that code for these mechan-
isms, along with 11 mosaic genes that code for ribosomal
protection proteins. Some of these genes, such as tet(C)
and tet(32), have only been found in Gram-positive
bacteria, while others such as tet(B) have only been
found in Gram-negative bacteria. In a recent study by
Chander et al., tet(B) was found in Streptococcus suis
isolated from pigs [5], but a lack of full sequencing of
the gene prevented the confirmation of such a finding.
In oral biofilm, streptococci are a great reservoir of
tetracycline resistance genes [6–8], and one of the
most common in the oral environment is S. oralis
[9]. S. oralis is a member of the Streptococcus mitis
group, known to be a commensal bacterium and
opportunistic pathogen [10]. S. oralis is an early
colonizer of the oral biofilm and plays an important
role in its establishment and homeostasis [11].
Moreover, it has been described to antagonize bac-
teria such as Streptococcus mutans, thus preventing
the development of dysbiotic biofilm [12]. However,
it is one of the most isolated bacteria in endocarditis
infections [13,14] and it has been found in numerous
types of infection sites [15–19].
Transformation among streptococci is a common
event, as they exhibit natural competence and easily
acquire foreign DNA. Therefore, the transference of
antibiotic resistance genes has been largely studied in
this genus [20,21]. Bacteria in the oral environment
tend to grow by forming a multispecies biofilm, which
increases the chances of horizontal gene transfer and
the spread of antimicrobial resistance, creating a large
reservoir of antibiotic resistance genes that could be
transferred to other bacteria, pathogenic or not [22].
In this study we described the presence of tet(B) in
two S. oralis isolates obtained from subgingival sam-
ples of healthy volunteers. Furthermore, in order to
prove the presence and transcription of the gene in
Gram-positive bacteria, the complete sequence of the
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gene was obtained, and its expression was evaluated
in both isolates.
Materials and methods
Sample collection and culture
Subgingival samples were collected from periodontally
healthy volunteers in the dental clinic of the Universitat
Internacional de Catalunya (UIC), (Barcelona, Spain),
and the research protocol was approved by the Ethics
Committee of the UIC (study number: PER-ECL
-2011–06-NF). Subjects had not received antibiotics
3 months prior to the study and did not show signs of
gingivitis or periodontitis. Sterile paper points were
inserted into the gingival sulci of teeth 16, 21, 36 and 41
and kept in place for 20 sec. These paper points were
pooled in a vial containing 1.5 ml of sterilized reduced
transport fluid (RTF) without EDTA [23] and sent to the
laboratory at 4ºC for processing within 24 h. Samples
were serially diluted and plated on blood agar (Oxoid
Nutrient Broth No. 2; Oxoid Ltd, Basingstoke, UK) con-
taining 5% horse blood, hemin (5 mg/l), menadione
(1 mg/ml) and 8 µg/ml of tetracycline (Sigma Aldrich,
St. Louis, MO, USA) to screen for tetracycline resistant
bacteria. Incubation was performed at 37ºC in anaerobic
conditions, and after 72 h, all different colony morphol-
ogies were subcultured to obtain pure cultures. For each
selected isolate, liquid cultures with and without tetracy-
cline (8 µg/ml) were done using modified brain heart
infusion (brain heart infusion broth [37 g/l], yeast extract
[1 g/l], L-cysteine [0.1 g/l], sodium bicarbonate [2 g/l],
and supplementedwith hemin [5mg/l] and glutamic acid
[0.25%]). Cultures grew to an OD600 of 0.8–1 (≈ 10
8 cfu/
ml), when DNA and RNA extractions were performed.
Detection of tet(B)
DNA was extracted from all the isolates using the
QIAamp DNA Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions, quantified
using a Nanodrop 2000 UV-vis spectrophotometer
(Nanodrop Technologies, Wilmington, DE, USA) and
visualized in a 0.5% agarose gel stained with ethidium
bromide.
All the isolates were screened for a battery of tet genes
(data not shown). To detect tet(B) the primers tetB-F and
tetB-R were used (Table 1) with the following PCR con-
ditions: an initial denaturation of 5min at 95ºC, 30 cycles
of 30 sec of denaturation at 95ºC, 30 sec of annealing at
56.5ºC and 45 sec of extension at 72ºC, and a final
extension of 10 min at 72ºC. The result of the PCR was
visualized in a 3% agarose gel stained with ethidium
bromide, where a band of 242 bp could indicate the
presence of tet(B).
DNA sequencing
tet(B) was found in two isolates, 444.1 and 469.4,
from two different subjects. In order to identify
each isolate to the species level, the 16S rRNA, sodA
and groEL genes were amplified using the primers 27-
F and 1544-R, sodA-F and sodA-R, and groEL-F and
groEL-R, respectively (Table 1). The PCR products
were purified using the E.Z.N.A.® Gel extraction Kit
(Omega BIO-TEK, Norcross, GA, USA) and
sequenced by primer walking at the Genomics and
Bioinformatics Service of the Autonomous University
of Barcelona (Barcelona, Spain). Primers tetB-insert-F
and tetB-insert-R (Table 1) were used to fully
sequence the tet(B) gene. These primers amplified
the gene 41 bp upstream of the start codon and 72
bp downstream of the stop codon. The 1,319 bp
amplicons were obtained by PCR and were purified
and sequenced by primer walking as described above.
The sequences obtained were analyzed using BLASTn
software at https://blast.ncbi.nlm.nih.gov/Blast.cgi.
Reference sequences for alignment were obtained
from the database on http://faculty.washington.edu/
marilynr/, specifically the sequences with the acces-
sion numbers: J01830, AF223162, V00611, AL513383,
AJ277653, AF326777 and AP000342. Additionally,
other sequences of tet(B) from other species were
used to ensure better reliability: CP015434.1,
KX458222.1, CP015836.1, NG_048163.1 and
LN908249.1. Alignment was performed using the
Clustal Omega service at https://www.ebi.ac.uk/
Tools/msa/clustalo/.
RNA isolation and expression of tet(B) gene
RNA was extracted from liquid cultures with and with-
out tetracycline using the High Pure RNA Isolation kit
(Roche Diagnostics, Mannheim, Germany) according
to the instructions provided by the manufacturer. An
extra step to remove any remaining DNA was done
using the TURBO DNA-freeTM Kit (Thermo Fisher
Scientific, Vilnius, Lithuania). The absence of DNA in
the samples was verified by PCR using the sets of
primers tetB-RT-F/tetB-RT-R, and 16S-So-F/16S-So-R
(Table 1), visualizing the results in a 3% agarose gel. The
remaining RNA was quantified in a Qubit 4
Fluorometer using the Qubit RNA XR Assay Kit
(Thermo Fisher Scientific, Eugene, OR, USA), and its
integrity was verified on a 2% agarose gel.
Expression of tet(B) was measured by Quantitative
Reverse Transcription PCR (RT-qPCR). Reactions
were performed with a LightCycler® 480 II
Instrument using the LightCycler® 480 RNA Master
Hydrolysis Probes kit (Roche Diagnostics, Mannheim
Germany), following the instructions provided by the
manufacturer. The sets of primers tetB-RT and 16S-
So (Table 1) were used together with probes 45 and
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66 from the Roche Diagnostics’ Universal
ProbeLibrary for the genes tet(B) and 16S rRNA,
respectively. The RT-qPCR conditions were as fol-
lows: i) 75 ng of RNA were used in each reaction
for the synthesis of cDNA, which was performed at
63ºC for 3 min; ii) cycling conditions were 95ºC for
30 sec, followed by 45 cycles of 15 sec at 95ºC, 40 sec
at 60ºC and 1 sec at 72ºC. Data were analyzed using
the LightCycler® 480 Software 1.5. The 16S rRNA
gene was used as an endogenous control, and the
formula 2ΔCptet(B)/2ΔCp16S rRNA was used to evaluate
differences in the expression of tet(B) in the presence
and absence of tetracycline.
Construction of tet(M) defective mutants
Isolate 469.4 was found to harbor the gene tet(M).
Therefore, in order to determine the contribution of
tet(B) to the tetracycline resistance of this isolate,
disruption of the gene tet(M) was performed by
introducing the gene erm(B), which confers resis-
tance to erythromycin, between the positions 853
and 1,110 of the tet(M) gene. To this end, we
made a construct consisting of the gene erm(B)
surrounded by two sequences homologous to tet
(M), which we named M1 (the 5ʹ region) and M2
(the 3ʹ region). erm(B) was extracted by PCR using
the primers ermB-NdeI-F and ermB-HindIII-R from
a S. oralis clinical strain resistant to erythromycin
pertaining to the Dentaid Research Center
(Cerdanyola del Vallès, Spain) strain collection. M1
and M2 sequences were obtained by PCR from the
isolate 469.4 using the primers M1-F and M1-NdeI
-R for the M1 sequence, and M2-HindIII-F and M2-
R for the M2 sequence (Table 1). PCR products
were purified using the E.Z.N.A.® Gel extraction
Kit and digested with NdeI and HindIII (New
England Biolabs Inc., Ipswich, MA, USA). Digested
fragments were ligated using T4 ligase (Roche
Diagnostics, Mannheim, Germany) according to
the manufacturer’s instructions. The construct was
then purified using the E.Z.N.A.® Gel extraction Kit
and transformed into 469.4 by electroporation using
the Gene Pulser Xcell (BioRad, Hercules, CA, USA).
Electroporated cells were plated on blood agar plates
containing 5 µg/ml of erythromycin (Sigma Aldrich,
St. Louis, MO, USA) and incubated in anaerobic
conditions for 24–48 h. The recombination event
was confirmed by PCR using primers M1-F and
M2-R.
Antibiotic susceptibility testing
Susceptibility to tetracycline was tested in 444.1, 469.4
and 469.4Δtet(M)::erm(B)(EryR) using E-test strips
(Sigma Aldrich, St. Louis, MO, USA) according to
manufacturer’s instructions. Streptococcus pneumo-
niae ATCC 49619 was used as a quality control strain.
Results
Species identification and tet(B) sequences
From a library of 448 tetracycline resistant isolates (data
not shown), two isolates obtained from two different
subjects were found to carry the tet(B) gene. Sequencing
of the 16S rRNA gene revealed that both isolates were
S. oralis and shared the same sequence, which showed
100% identity with the 16S rRNA sequences from
S. oralis ATCC 700233, DSMZ 20,066 and CIP
103216. To further corroborate this result, sequences
of the genes sodA and groEL were also aligned to strep-
tococcal sequences, observing the highest homology
with S. oralis sequences. To ensure the presence of tet
(B), full sequencing of the gene and further alignment
against reference sequences was performed, showing an
identity of 99.99–100% of the tet(B) isolated in this
study. Sequence J01830 was used as a reference, being
Table 1. List of primers used in this study.
Primers Sequence 5ʹ – 3’ Product size (bp) Annealing Temp (°C) Reference
27-F
1544-R
AGA GTT TGA TCC TGG CTC AG




CCI TAY ICI TAY GAY GCI YTI GAR CC




GAH GTN GTI GAA GGI ATG CA




TTG GTT AGG GGC AAG TTT TG




ACC AAA GCT TAG TTA TTC TAC CAC TCC CTA TCA GT
CTT CTT CGA ATG CCC TCT TGG GTT ATC AAG
1,319 53 This study
tetB-RT-F
tetB-RT-R
TTC AAG TGC GCT TTG GAT GC
CGT TGA GAA GCT GAG GTG GT
111 60 This study
16S-So-F
16S-So-R
CGC TCG GGA CCT ACG TAT TA
TAC CAG AAA GGG ACG GCT AA
59 60 This study
M1-F
M1-NdeI-R
GAT TTT TTA GCA GAA GTA
CCG ATA CCA TAT GCC GAT ATT CTA ACC GAA T
629 55 This study
M2-HindIIIF
M2-R
CCG ATA CAA GCT TAG TGA CCC GCT TCT GCG A
GAC TAT TTG GAC GAC GGG
782 55 This study
ermB-NdeI-F
ermB-HindIII-R
GCG TTA GCA TAT GTA CGT TAG ATT AAT TCC TAC CAG
CCG ATA CAA GCT TTT ATT TCC TCC CGT TAA ATA
887 55 This study
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the first published sequence of tet(B) [24]. Point muta-
tions were found in all of the sequences used compared
to J01830 (Supplementary Figure 1). tet(B) sequences of
isolates 444.1 and 469.4, as well as sequences AF223162,
AF326777, AL513383, CP015836.1, KX458222.1,
LN908249.1 and NG_048163.1, presented five point
mutations in positions 463, 794, 854, 940 and 1012.
Sequence CP015434.1 exhibited an additional point
mutation in position 1,140, and sequence AP000342
had four of these point mutations in positions 794,
854, 940 and 1,012. All these mutations resulted in
amino acid substitutions with the exception of the
mutations in position 1,140 (Table 2 and
Supplementary Figure 2).
Sequences obtained in this study were submitted to
GenBank (https://www.ncbi.nlm.nih.gov/genbank/),
and the following accession numbers were retrieved:
MK611935 and MK611934 for the 16S rRNA gene of
444.1 and 469.4, respectively, and MK611936 and
MK611937 for the tet(B) gene of 444.1 and 469.4,
respectively.
Expression of tet(B)
The level of expression of tet(B) in isolates 444.1 and
469.4 was determined comparing log-phase liquid
cultures with and without tetracycline of each isolate.
The exposure to tetracycline did not decrease the
growth rate of the bacteria recovered from the culture
and yielded similar amounts of RNA.
A transcriptional analysis of the gene tet(B) was
performed using RT-qPCR. tet(B) mRNA was detected
in isolate 469.4 but not in isolate 444.1, despite showing
very similar levels of 16S rRNA expression (Figure 1).
As for isolate 469.4, no differences were observed in the
expression of tet(B) when applying tetracycline to the
medium. The gene expression value, normalized with
the 16S rRNA gene, was 0.06 (log2).
According to previous screening for tet genes,
isolate 469.4 contained a tet(M) gene in addition
to tet(B). In order to determine the influence of tet
(B) on the tetracycline resistance of the isolate
469.4, the mutant 469.4Δtet(M)::erm(B)(EryR) was
constructed.
Antibiotic susceptibility
Susceptibility to tetracycline was tested in isolates
444.1 and 469.4 using E-test strips, observing
a minimum inhibitory concentration (MIC) of 32 µg/
ml to tetracycline. In order to assess whether tetracy-
cline resistance was being conferred by the gene tet(M)
as opposed to tet(B), susceptibility to tetracycline in
the mutant strain 469.4Δtet(M)::erm(B)(EryR) was also
tested, observing a MIC of 32 µg/ml.
Discussion
Resistance to tetracyclines is widespread, and although
tetracyclines are still useful in some treatments, only the
most recent versions are being used to treat multidrug
Table 2. Positions of nucleotide substitutions in the tet(B) sequences used as comparison. Between parentheses, the positions
and amino acid substitutions corresponding to each nucleotide substitution. NC: no changes.
Nucleotide substitution
Sequences 463A>G (Thr155Ala) 794A>G (Glu265Gly) 854A>T (Asp285Val) 940G>C (Glu314Gln) 1012A>G (Thr338Ala) 1140A>G (NC)
469.4 + + + + +
444.1 + + + + +
AF223162 + + + + +
AF326777 + + + + +
AL513383 + + + + +
CP015836.1 + + + + +
KX458222.1 + + + + +
LN908249.1 + + + + +
NG_048163.1 + + + + +
CP015434.1 + + + + + +





















444 16S w TC
444 16S w/o TC
469 16S w TC
469 16S w/o TC
444 tet(B) w TC
444 tet(B) w/o TC
469 tet(B) w TC
469 tet(B) w/o TC
Figure 1. Amplification curves of the 16S rRNA and tet(B) genes obtained by RT-qPCR from RNA of 444.1 and 469.4.
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resistant bacteria [25]. Nevertheless, a new formulation
of minocycline, a second generation tetracycline, has
been proven effective against MDR A. baumannii infec-
tions, allowing an old antibiotic to be used again [4,25].
Unfortunately, resistance to these antibiotics is possible
through differentmechanisms such as efflux pumps like
the one coded by tet(B), which can recognize different
tetracyclines as substrates, including minocycline, dox-
ycycline and even glycylcyclines through punctual
mutations [26]. tet(B) is the most distributed tetracy-
cline resistance gene among Gram-negatives [27] and
so far it has not been described in Gram-positives.
However, a recent study [5] reported to have found tet
(B) in S. suis, being the first time to describe the pre-
sence of this gene in a Gram-positive bacteria.
Nonetheless, and although sequencing was performed
and 100% identity was obtained, only 54.55% of the
gene was covered, raising doubts of whether the gene
might or might not be tet(B). According to Levy et al.
[28], tetracycline resistance determinants should have ≤
80% of amino acid identity in order to be considered
different genes, which makes it impossible for the pre-
viously discussed analysis to determine if the gene stu-
died was tet(B).
In our study we found two isolates of S. oralis
susceptible of carrying tet(B). In both cases, we
performed full sequencing of the gene, resulting
in 100% coverage, and compared the sequences to
those tet(B) sequences previously published, show-
ing some minor differences involving up to six
nucleotides in a sequence of 1,206 base pairs,
which led to up to five amino acid substitutions
in a sequence of 401 amino acids (100% – 98.75%
identity). Most of the polymorphisms observed in
the tet(B) sequences obtained from isolates 444.1
and 469.4 were shared by all the published
sequences used in this study with the exception of
V00611 and AJ277653, which were identical to the
reference sequence J01830 (Table 2). These three
sequences were obtained from Escherichia coli,
although CP015836.1, another E. coli sequence
used in this study, presented five point mutations
compared to J01830, implying that these mutations
might have occurred at some point during replica-
tion or transference and were maintained in certain
strains.
tet(B) expression was studied to understand the
functionality of the gene in the two S. oralis isolates
obtained. It is known that, in the presence of tetra-
cycline, the transcription of tetracycline resistance
genes is induced [29,30]. For this reason, cultures
were made with and without tetracycline and RNA
was extracted to quantify the expression of the
gene. tet(B) mRNA could only be found in isolate
469.4, meaning that the gene was not being
expressed under those conditions in isolate 444.1.
Furthermore, expression in 469.4 seemed to be
constitutive, since its transcription did not depend
on the addition of tetracycline, as it was observed
once normalized with the expression values of the
16S rRNA gene. Both isolates carried tet(M) as
well, which might have conferred resistance to tet-
racycline, as opposed to tet(B). We disabled the tet
(M) gene in the 469.4 isolate through homologous
recombination to determine its role in the level of
tetracycline resistance, and we found no changes in
the level of susceptibility, indicating that tet(B)
could be responsible for tetracycline resistance in
isolate 469.4, although it cannot be ruled out that
resistance to tetracycline could be provided by
another gene or mechanism.
The presence of tet(B) in Gram-positive bacteria
is another step in the dissemination of antibiotic
resistance genes. Although tet(B) seemed to be
expressed in only one of the isolates, the presence
of this tetracycline resistance gene had never been
confirmed in Gram positives. Whether tet(B) is
being expressed or not, it seems clear that the
reservoir for this gene has expanded to the genus
Streptococcus, an enormous bacterial group,
increasing the chances for its dissemination. The
transfer of antibiotic resistance genes between
Gram-positive and Gram-negative bacteria has
been previously reported [31-33], and the oral
environment offers a great opportunity for these
transfers to occur. The characteristics of the oral
biofilm make it prone to genetic exchange, allowing
the bacteria that live in such environment to
acquire and share antibiotic resistance genes,
among others [22,34-36]. Furthermore, the oral
environment is a transit area for many bacteria
that might end up in other niches of the human
body, thus creating the opportunity for these bac-
teria to acquire genetic determinants present in the
oral microbiome. Given that the tet(B) sequence
analyzed in this study was identical to other
sequences of tet(B) observed in Gram-negatives,
the functionality of this gene, being transferred to
Gram-negatives, would be expected. In this study
we confirmed the presence and expression of the
gene tet(B) in Gram-positive bacteria. However,
further studies should be conducted in order to
establish the function of the gene tet(B) in isolates
444.1 and 469.4. Moreover, a full characterization
of the surroundings of the gene and its ability to
transfer among other streptococci might help to
understand the actual potential of the tet(B) gene
in Gram-positive bacteria.
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